Robert J. Behrens, MD
Robert J. Behrens, MD
Attending Physician
Iowa Oncology Research Association
300 E Locust St
Des Moines,
IA
USA
50309
Papers:
53
A phase II trial of trebaninib (AMG 386), a selective angiopoietin 1/2 neuralizing peptibody in patients with persistent/recurrent carcinoma of the endometrium: a Gynecologic Oncology Group study